Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04352621
Status:
UNKNOWN
Last Update Posted:
2020-04-20
First Post:
2020-02-16
Brief Title:
Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder TRD
Sponsor:
University of Cincinnati
Organization:
University of Cincinnati
Study Overview
Official Title:
Ketamine Enhancement of rTMS for Refractory Depression
Status:
UNKNOWN
Status Verified Date:
2020-04
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An open label study to assess the safety tolerability and effects of intranasal Ketamine in combination with rTMS for patients with treatment-resistant major depressive disorder TRD Patients will be given a dose of ketamine followed by 6 weeks of rTMS treatment
Detailed Description:
Investigate the effects of pretreatment using a single sub-anesthetic dose of intranasal ketamine on the response to a standard course of rTMS in patients who meet the definition of TRD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None